Product Details:
Minimum Order Quantity | 100 Bottle |
Brand Name | ZICSEF 50 MG |
Manufacturer | SELF |
Strength | 50MG |
Form | Oral Suspension |
Packaging Size | 30 ML |
Packaging Type | BOTTLE |
Usage | Clinical, Hospital |
Additional Information:
Product Details:
Minimum Order Quantity | 120 Piece |
Form Of Supplement | syp |
Type Of Supplement | Calcium |
Packaging Type | 200ml |
Packaging Size | 200ml |
Type | Syrup |
Additional Information:
Product Details:
Strength | Piroxicam 20mg Dispersible Tab |
Packaging Size | 10*10 |
Brand | voycam 20 dt |
Composition | Piroxicam 20mg Dispersible Tab |
Manufacturer | own |
Prescription/Non prescription | Prescription |
Form | Tablet |
Dosage Form | Tablet |
Also Gives | Third Party Manufacturing, PCD Pharma Franchise |
Country of Origin | Made in India |
Product Details:
Minimum Order Quantity | 100 Bottle |
Packaging Size | 5 ml |
Composition | ofloxacin susp |
Prescription/Non prescription | Prescription |
Packaging Type | Bottle |
Brand | FLOZOX RA |
Usage | Clinical, Hospital |
Manufactured By | BAJAJ FORMULATIN |
Usage/Application | Hospital |
Form | Syrup |
Shelf Life | 2 YEAR |
Country of Origin | Made in India |
COMPOSITION | PACKING |
OFLOXACIN 50MG + ORNIDAZOLE 125MG + RACECADOTRIL 15MG SUSP | 30 ML |
Product Details:
Minimum Order Quantity | 50 Bottle |
Product Type | Finished Product |
Pharmaceutical Experience | Yes |
Packaging Type | Bottle |
Usage | Clinical |
Additional Information:
Product Details:
Minimum Order Quantity | 200 Bottle |
Dose | 60ml |
Brand | ALCOMEF-P |
Packaging Type | Bottle |
Usage | Commercial |
Product Details:
Dosage Form | Syrup |
Packaging Size | 170 ml |
Brand | Ulcidra M susp |
Additional Information:
Product Details:
Minimum Order Quantity | 100 Piece |
Product Type | Finished Product |
Usage | Commercial, Clinical, Hospital, Clinical, Hospital |
Packaging Size | 15ML |
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications.
Azithromycin should not be used in patients with pneumonia who are judged to be inappropriate for oral therapy because of moderate to severe illness or risk factors such as any of the following:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Additional Information: